CLS Americas and URN Announce Treatment of 20th & Final Patient in Clinical Study

CLS Americas announces the full twenty patients have been safely treated in the Phase I clinical study titled, “Targeted MRI/US Fusion Transperineal Laser Ablation of Low-to-Intermediate Risk Prostate Cancer.” The study utilizes CLS’s TRANBERG® Thermal Therapy System in combination with the Focalyx® Fusion medical device for treatment organization, planning, image fusion, and real-time image guidance during the high-precision, focal laser ablation (FLA) treatment.

The study is being conducted by Urological Research Network, LLC, a Florida-based, not-for-profit clinical research organization.

Read the full press release here.

Welcome to Clinical Laserthermia Systems.

Please note that all our products and indications are not yet approved in all markets. Don’t hesitate to contact us for up-to-date market approvals in your area!

Please choose your country or region